Market Overview:
The global medical angioplasty balloons market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in medical angioplasty balloons, and rising demand for minimally invasive procedures. Based on type, the global medical angioplasty balloons market is segmented into normal balloons, drug eluting balloons, cutting balloons, scoring ballsons and others. The normal balloon segment is expected to dominate the market during the forecast period owing to its low cost and high availability. However, the drug eluting balloon segment is projected to grow at a higher CAGR due its ability to reduce restenosis rates as compared with other types of medical angioplasty balloons. Based on application, hospitals are estimated account for majority share of revenue generated by sale of medical angipolystyrene ballsons globally followed by clinics during 2018-2030 .
Product Definition:
Medical angioplasty balloons are devices that are inserted into narrowed or blocked arteries in order to widen them and improve blood flow. They are typically made from a soft, flexible plastic and come in a variety of shapes and sizes. Once inflated, they push against the artery walls to create more space for blood to flow through.
Normal Balloons:
Normal balloons are latex-based, round, hollow spheres that are used in medical procedures for the purpose of angioplasty. They are designed to be inflated inside a blood vessel and then the doctor inserts a catheter into the patient and injects the inflation fluid which causes it to expand thus creating a balloon sized opening in the blood vessel wall.
Drug Eluting Balloons:
Drug eluting balloons (DEBs) are used in the treatment of coronary artery disease. They consist of a thin, hollow, plastic balloon filled with a mixture of drugs that prevent the uptake of cholesterol by arteries and veins. The DEB is then inserted into the patient's body and it slowly dissolves over a period of 3 to 6 months thereby reducing the build-up of plaque in coronary arteries.
Application Insights:
Based on application, the global medical angioplasty balloons market is segmented into hospitals, clinics and other medical facilities, and others. Hospitals held the largest share in 2017 owing to factors such as a high prevalence of cardiovascular diseases in this region coupled with increasing awareness about these procedures. According to data published by WHO in 2018, out of which around USD 8 billion worth cardiology procedures are performed annually worldwide while over USD 37 billion worth heart disease is suffered by people across the world.
The use of advanced products has also increased significantly over recent years which has led to better outcomes for patients suffering from various forms of heart conditions or diseases. For instance, stents are now available that not only prevent blood clotting but also reduce inflammation at a cellular level thereby improving long term results after surgery.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, high healthcare expenditure, and increasing prevalence of cardiovascular diseases. The U.S. is one of the most developed countries regarding medical technologies and equipment with a well-developed healthcare system at both public and private levels.
Growth Factors:
- Increasing incidence of cardiovascular diseases: The increasing incidence of cardiovascular diseases is one of the key growth drivers for the medical angioplasty balloons market. According to a study by the World Health Organization (WHO), an estimated 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. This number is projected to increase to 23 million by 2030. This growing prevalence of cardiovascular diseases is expected to drive demand for medical angioplasty balloons over the forecast period.
- Technological advancements: The medical angioplasty balloons market is witnessing significant technological advancements, with manufacturers introducing new products and technologies that offer better performance and safety profiles than traditional devices. For instance, in 2016, Boston Scientific Corporation introduced its Lotus Edge balloon catheter system, which offers superior deliverability and conformability compared to other devices in its class. These technological advancements are expected to boost demand for medical angioplasty balloons over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Angioplasty Balloons Market Research Report
By Type
Normal Balloons, Drug Eluting Balloons, Cutting Balloons, Scoring Balloons,
By Application
Hospitals, Clinics, Others,
By Companies
Medtronic, Boston Scientific Corporation(US), Johnson & Johnson, Abbott, C.R. Bard, Cardinal Health, Spectranetics, Biotronik, Cook Medical, Endocor, B. Braun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Medical Angioplasty Balloons Market Report Segments:
The global Medical Angioplasty Balloons market is segmented on the basis of:
Types
Normal Balloons, Drug Eluting Balloons, Cutting Balloons, Scoring Balloons,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific Corporation(US)
- Johnson & Johnson
- Abbott
- C.R. Bard
- Cardinal Health
- Spectranetics
- Biotronik
- Cook Medical
- Endocor
- B. Braun
Highlights of The Medical Angioplasty Balloons Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Normal Balloons
- Drug Eluting Balloons
- Cutting Balloons
- Scoring Balloons
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Angioplasty Balloons Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical Angioplasty Balloons are a type of medical device that is used to help open blocked blood vessels. They are made from a thin, flexible material and are inflated using air or gas. When the balloon is inflated, it expands and pushes against the wall of the blood vessel. This can help to break up the blockage and allow more blood flow through the vessel.
Some of the major companies in the medical angioplasty balloons market are Medtronic, Boston Scientific Corporation(US), Johnson & Johnson, Abbott, C.R. Bard, Cardinal Health, Spectranetics, Biotronik, Cook Medical, Endocor, B. Braun.
The medical angioplasty balloons market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Angioplasty Balloons Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Angioplasty Balloons Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Angioplasty Balloons Market - Supply Chain
4.5. Global Medical Angioplasty Balloons Market Forecast
4.5.1. Medical Angioplasty Balloons Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Angioplasty Balloons Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Angioplasty Balloons Market Absolute $ Opportunity
5. Global Medical Angioplasty Balloons Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Angioplasty Balloons Market Size and Volume Forecast by Type
5.3.1. Normal Balloons
5.3.2. Drug Eluting Balloons
5.3.3. Cutting Balloons
5.3.4. Scoring Balloons
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Angioplasty Balloons Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Angioplasty Balloons Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Angioplasty Balloons Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Angioplasty Balloons Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Angioplasty Balloons Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Angioplasty Balloons Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Angioplasty Balloons Demand Share Forecast, 2019-2026
9. North America Medical Angioplasty Balloons Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Angioplasty Balloons Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Angioplasty Balloons Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Angioplasty Balloons Market Size and Volume Forecast by Type
9.7.1. Normal Balloons
9.7.2. Drug Eluting Balloons
9.7.3. Cutting Balloons
9.7.4. Scoring Balloons
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Angioplasty Balloons Demand Share Forecast, 2019-2026
10. Latin America Medical Angioplasty Balloons Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Angioplasty Balloons Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Angioplasty Balloons Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Angioplasty Balloons Market Size and Volume Forecast by Type
10.7.1. Normal Balloons
10.7.2. Drug Eluting Balloons
10.7.3. Cutting Balloons
10.7.4. Scoring Balloons
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Angioplasty Balloons Demand Share Forecast, 2019-2026
11. Europe Medical Angioplasty Balloons Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Angioplasty Balloons Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Angioplasty Balloons Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Angioplasty Balloons Market Size and Volume Forecast by Type
11.7.1. Normal Balloons
11.7.2. Drug Eluting Balloons
11.7.3. Cutting Balloons
11.7.4. Scoring Balloons
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Angioplasty Balloons Demand Share, 2019-2026
12. Asia Pacific Medical Angioplasty Balloons Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Angioplasty Balloons Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Angioplasty Balloons Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Angioplasty Balloons Market Size and Volume Forecast by Type
12.7.1. Normal Balloons
12.7.2. Drug Eluting Balloons
12.7.3. Cutting Balloons
12.7.4. Scoring Balloons
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Angioplasty Balloons Demand Share, 2019-2026
13. Middle East & Africa Medical Angioplasty Balloons Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Angioplasty Balloons Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Angioplasty Balloons Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Angioplasty Balloons Market Size and Volume Forecast by Type
13.7.1. Normal Balloons
13.7.2. Drug Eluting Balloons
13.7.3. Cutting Balloons
13.7.4. Scoring Balloons
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Angioplasty Balloons Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Angioplasty Balloons Market: Market Share Analysis
14.2. Medical Angioplasty Balloons Distributors and Customers
14.3. Medical Angioplasty Balloons Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation(US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson & Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. C.R. Bard
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cardinal Health
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Spectranetics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biotronik
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cook Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Endocor
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. B. Braun
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
